Evidence map›Paper›PMID 22969084›Full record

ArticleThe Journal of biological chemistry2012

Characterization of an actin-targeting ADP-ribosyltransferase from Aeromonas hydrophila.

Adin Shniffer, Danielle D Visschedyk, Ravikiran Ravulapalli, Giovanni Suarez, Zachari J Turgeon, Anthony A Petrie, Ashok K Chopra, A Rod Merrill

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Antagonistic effects of actin-specific toxins onbioRxiv : the preprint server for biology · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. The natural history of ADP-ribosyltransferases and the ADP-ribosylation system.Current topics in microbiology and immunology · 2015
    Review
  8. Arginine ADP-ribosylation mechanism based on structural snapshots of iota-toxin and actin complex.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Adin ShnifferDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario N1G 2W1, Canada.
Danielle D Visschedyk
Ravikiran Ravulapalli
Giovanni Suarez
Zachari J Turgeon
Anthony A Petrie
Ashok K Chopra
A Rod Merrill
University of Guelph · CAThe University of Texas Medical Branch at Galveston · US

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

The mono-ADP-ribosyltransferase (mART) toxins are contributing factors to a number of human diseases, including cholera, diphtheria, traveler's diarrhea, and whooping cough. VahC is a cytotoxic, actin-targeting mART from Aeromonas hydrophila PPD134/91. This bacterium is implicated primarily in diseases among freshwater fish species but also contributes to gastrointestinal and extraintestinal infections in humans. VahC was shown to ADP-ribosylate Arg-177 of actin, and the kinetic parameters were K(m)(NAD(+)) = 6 μM, K(m)(actin) = 24 μM, and k(cat) = 22 s(-1). VahC activity caused depolymerization of actin filaments, which induced caspase-mediated apoptosis in HeLa Tet-Off cells. Alanine-scanning mutagenesis of predicted catalytic residues showed the predicted loss of in vitro mART activity and cytotoxicity. Bioinformatic and kinetic analysis also identified three residues in the active site loop that were critical for the catalytic mechanism. A 1.9 Å crystal structure supported the proposed roles of these residues and their conserved nature among toxin homologues. Several small molecules were characterized as inhibitors of in vitro VahC mART activity and suramin was the best inhibitor (IC(50) = 20 μM). Inhibitor activity was also characterized against two other actin-targeting mART toxins. Notably, these inhibitors represent the first report of broad spectrum inhibition of actin-targeting mART toxins.

Indexed as

Actin CytoskeletonActinsADP Ribose TransferasesAeromonas hydrophilaAmino Acid MotifsApoptosisBacterial ProteinsBacterial ToxinsCatalytic DomainCell ShapeCrystallography, X-RayEnzyme InhibitorsHeLa CellsHumansKineticsModels, MolecularActinsADP Ribose TransferasesBacterial ProteinsBacterial ToxinsEnzyme Inhibitors

Identifiers

PMID22969084
PMCPMC3481304
OpenAlexW1966332718

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.